Common Chemical Tied to Diabetes in Seniors

Key points
- Serum levels of phthalate metabolites are linked with the development of type 2 diabetes in the elderly, Swedish researchers found.
- "Phthalates are found in numerous household products, such as food packaging, furniture, and toys, and in medical devices, such as tubing and intravenous bags," researchers P.
- After further adjustment for cholesterol, triglycerides, body mass index, smoking, exercise, and education, MiBP remained significantly related to diabetes (OR 1.30, 95% CI 1.10 to 1.55, P=0.0025), Lind and colleagues they found.
- Phthalates also are commonly found in cosmetics and pharmaceutical products, and concerns have been raised about potential adverse health consequences associated with exposure.
Serum levels of phthalate metabolites are linked with the development of type 2 diabetes in the elderly, Swedish researchers found.
"Phthalates are found in numerous household products, such as food packaging, furniture, and toys, and in medical devices, such as tubing and intravenous bags," researchers P. Monica Lind, PhD, from Uppsala University, and colleagues noted.
After adjustment for sex, diabetes was significantly associated with the presence of monoethyl phthalate (MEP), with an odds ratio of 1.30 (95% CI 1 to 1.69, P=0.049) as well as with detectable monoisobutyl phthalate (MiBP), with an odds ratio of 1.25 (95% CI 1.07 to 1.46, P=0.006), they reported in the June issue of Diabetes Care..
After further adjustment for cholesterol, triglycerides, body mass index, smoking, exercise, and education, MiBP remained significantly related to diabetes (OR 1.30, 95% CI 1.10 to 1.55, P=0.0025), Lind and colleagues they found.
Phthalates also are commonly found in cosmetics and pharmaceutical products, and concerns have been raised about potential adverse health consequences associated with exposure.
Phthalates can bind to certain receptors involved in homeostasis of fats and lipids known as nuclear peroxisome proliferator-activator receptors (PPARs), and PPAR antagonists are used to treat type 2 diabetes.
To explore a possible relationship between these chemical metabolites and diabetes, the investigators analyzed data from a prospective study of 1,016 elderly residents of Uppsala.
They sought to measure serum levels of 10 phthalate metabolites, but only levels of MEP, MiBP, monomethyl phthalate (MMP), and mono(2-ethylhexyl) phthalate (MEHP) were detectable at levels of 0.2 ng/mL in most study participants.
Glucose tests were done after an overnight fast, and diabetes was identified in 119 individuals.
Analysis showed that patients in the highest quintiles of MEP, MiBP, and MMP levels had double or more the risk of diabetes compared with the lowest quintiles, with odds ratios ranging from 2 to 2.50.
But the highest risk was for individuals with MEP in the third quintile (OR 2.87, 95% CI 1.37 to 6.03, P=0.005).
Both MEHP and MiBP had significant associations with elevated proinsulin-to-insulin ratios, while MEP and MMP were related to a high insulin resistance index.
The researchers noted that MEP, MiBP, and MMP all are metabolites of related compounds that are most commonly used in personal care products, while the use of MEPH is primarily to increase the flexibility of plastic.
They hypothesized that the mechanism by which phthalates contribute to diabetes was probably through effects on PPARs.
"Because phthalate metabolites are known ligands to PPARs, receptors known to influence glucose homeostasis, impairments in PPAR-signaling pathways are most likely to contribute to the actions of phthalates on glucose metabolism and diabetes development," they explained.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Diabetes & Hormones →
NewsBiologists discover biochemical link between biological clock and diabetes
Biologists have found that a key protein that regulates the biological clocks of mammals also regulates glucose production in the liver and that altering the levels of this protein can improve the health of diabetic…
20 September 2010
NewsCommon diabetes drug linked to vitamin deficiency
Patients treated over long periods with metformin, a common drug for diabetes, are at risk of developing vitamin B12 deficiency which is also likely to get worse over time, according to a study published on Friday.…
22 May 2010
NewsGenetic mutations identified that suggest link between type 1 diabetes and common viral infection
Scientists from Cambridge University have discovered four rare mutations of a gene associated with type 1 diabetes (T1D) that reduce the risk of developing the disease. Their findings, published today in the journal…




